Crossmark

Matching-Adjusted Indirect Comparison of Blinatumomab vs. Inotuzumab Ozogamicin for Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia

Published Online: 2019-02-13

Published Print: 2019-04-01

Authors

Song, Jinlin

Ma, Qiufei

Gao, Wei

Cong, Ze

Xie, Jipan

Zimmerman, Zachary

Belton, Laura

Franklin, Janet

Palmer, Stephen
Funding

Funding for this research was provided by:

Amgen
License Information

Text and Data Mining valid from 2019-02-13

Version of Record valid from 2019-02-13
More Information

Article History

Received: 10 December 2018

First Online: 13 February 2019

Document is current